0000919574-11-004815.txt : 20110815 0000919574-11-004815.hdr.sgml : 20110815 20110815123455 ACCESSION NUMBER: 0000919574-11-004815 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110630 FILED AS OF DATE: 20110815 DATE AS OF CHANGE: 20110815 EFFECTIVENESS DATE: 20110815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Broadfin Capital, LLC CENTRAL INDEX KEY: 0001511901 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-14251 FILM NUMBER: 111034569 BUSINESS ADDRESS: STREET 1: 237 PARK AVENUE, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-808-2463 MAIL ADDRESS: STREET 1: 237 PARK AVENUE, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 13F-HR 1 d1216810_13f-hr.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F Cover Page Report for the Calendar Year or Quarter Ended: June 30, 2011 Check here if Amendment: |_|; Amendment Number: ____ This Amendment (Check only one): |_| is a restatement |_| adds new holding entries. Institutional Manager Filing this Report: Name: Broadfin Capital, LLC Address: 237 Park Avenue Ninth Floor New York, NY 10017 13F File Number: 028-14251 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Kevin Kotler Title: Managing Member Phone: (212) 808-2460 Signature, Place and Date of Signing: /s/ Kevin Kotler New York, New York August 15, 2011 ------------------- --------------------------- -------------------- [Signature] [City, State] [Date] Report Type: (Check only one): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report). [_] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting managers(s).) [_] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: None Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 1 Form 13F Information Table Entry Total: 43 Form 13F Information Table Value Total: $182,628 (thousands) List of Other Included Managers: Form 13F File Number Name (1) 028-14254 Broadfin Healthcare Master Fund, Ltd. FORM 13F INFORMATION TABLE

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY NAME OF ISSUER TITLE OF CLASS CUSIP (X$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE -------------- --------------- ------ --------- -------- --- ----- ----------- --------- ----- ------ ---- ACCURAY INC COM 004397105 2,771 345,962 SH DEFINED 1 345,962 ALIGN TECHNOLOGY INC COM 016255101 4,796 210,351 SH DEFINED 1 210,351 ALKERMES INC COM 01642T108 16,182 870,000 SH DEFINED 1 870,000 ALLOS THERAPEUTICS INC COM 019777101 2,373 1,108,800 SH DEFINED 1 1,108,800 ALNYLAM PHARMACEUTICALS INC COM 02043Q107 1,874 200,000 SH DEFINED 1 200,000 ALPHATEC HOLDINGS INC COM 02081G102 3,091 888,127 SH DEFINED 1 888,127 ANACOR PHARMACEUTICALS INC COM 032420101 4,399 680,975 SH DEFINED 1 680,975 ANGIODYNAMICS INC COM 03475V101 5,373 377,607 SH DEFINED 1 377,607 ANTARES PHARMA INC COM 036642106 4,450 2,013,518 SH DEFINED 1 2,013,518 ATRICURE INC COM 04963C209 3,785 293,411 SH DEFINED 1 293,411 BIONOVO INC COM NEW 090643206 689 901,200 SH DEFINED 1 901,200 BIOSANTE PHARMACEUTICALS INC COM NEW 09065V203 2,068 752,047 SH DEFINED 1 752,047 CALIPER LIFE SCIENCES INC COM 130872104 1,633 201,300 SH DEFINED 1 201,300 CARDICA INC COM 14141R101 369 135,000 SH DEFINED 1 135,000 CONCEPTUS INC COM 206016107 4,668 400,000 SH DEFINED 1 400,000 COVIDIEN PLC SHS G2554F113 6,920 130,000 SH DEFINED 1 130,000 CUTERA INC COM 232109108 329 38,555 SH DEFINED 1 38,555 DYAX CORP COM 26746E103 792 400,000 SH DEFINED 1 400,000 GENMARK DIAGNOSTICS INC COM 372309104 1,338 228,717 SH DEFINED 1 228,717 GENOMIC HEALTH INC COM 37244C101 210 7,520 SH DEFINED 1 7,520 GIVEN IMAGING ORD SHS M52020100 2,258 110,974 SH DEFINED 1 110,974 HI-TECH PHARMACAL INC COM 42840B101 13,749 475,240 SH DEFINED 1 475,240 HOSPIRA INC COM 441060100 5,708 100,747 SH DEFINED 1 100,747 INTELLIPHARMACEUTICS INTL IN COM 458173101 3,410 856,851 SH DEFINED 1 856,851 KINETIC CONCEPTS INC COM NEW 49460W208 4,368 75,800 SH DEFINED 1 75,800 LANNET INC COM 516012101 6,515 1,308,274 SH DEFINED 1 1,308,274 MEDICIS PHARMACEUTICAL CORP CL A NEW 584690309 4,199 110,000 SH DEFINED 1 110,000 MERIT MED SYS INC COM 589889104 3,217 179,022 SH DEFINED 1 179,022 NXSTAGE MEDICAL INC COM 67072V103 3,521 169,100 SH DEFINED 1 169,100 PAIN THERAPEUTICS INC COM 69562K100 1,064 275,000 SH DEFINED 1 275,000 PALOMAR MED TECHNOLOGIES INC COM NEW 697529303 1,171 103,768 SH DEFINED 1 103,768 PROGENICS PHARMACEUTICALS IN COM 743187106 5,019 699,044 SH DEFINED 1 699,044 PROSHARES TR PSHS ULSHRUS2000 74348A202 4,176 100,000 SH DEFINED 1 100,000 QLT INC COM 746927102 1,679 232,876 SH DEFINED 1 232,876 RIGEL PHARMACEUTICALS INC COM NEW 766559603 8,786 958,148 SH DEFINED 1 958,148 ROCKWELL MEDICAL TECH COM 774374102 574 44,691 SH DEFINED 1 44,691 SANOFI SPONSORED ADR 80105N105 9,149 227,765 SH DEFINED 1 227,765 SANTARUS INC COM 802817304 13,901 4,125,000 SH DEFINED 1 4,125,000 SOLTA MED INC COM 83438K103 690 250,000 SH DEFINED 1 250,000 ST JUDE MED INC COM 790849103 2,411 50,563 SH DEFINED 1 50,563 STRYKER CORP COM 863667101 2,952 50,300 SH DEFINED 1 50,300 TEVA PHARMACEUTICAL INDS LTD ADR 881624209 14,244 295,400 SH DEFINED 1 295,400 WUXI PHARMATECH CAYMAN INC SPONS ADR SHS 929352102 1,756 100,000 SH DEFINED 1 100,000

SK 25125 0001 1216810